Human phosphatase biology company
Anavo Therapeutics has raised €8.5M across 1 funding round from 5 investors, most recently a Seed round in May 2023. Based in Leiden, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-02 | Seed | €8.5M |
| Bioqube Ventures,INKEF Capital,M Ventures,MRL Ventures Fund,Taiho Ventures |
| View deal → |
